Retrospective Analysis of Real World Use of Ceftazidime-avibactam in the Management of Gram Negative Infections

Clinical trial NCT04628572 · COMPLETED

Trial details

NCT number: NCT04628572
Sponsor: Pfizer
Status: COMPLETED
Study type: OBSERVATIONAL

Gram Negative Infections

Start date: 2021-01-29
Primary completion: 2022-03-11
Enrollment: 189

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.